Cempra Holdings LLC PT Raised to $19.00 (CEMP)
Stifel Nicolaus upped their target price on shares of Cempra Holdings LLC (NASDAQ:CEMP) from $13.00 to $19.00 in a research note issued on Wednesday, American Banking News.com reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 60.34% from the stock’s previous close.
Shares of Cempra Holdings LLC (NASDAQ:CEMP) traded up 6.37% during mid-day trading on Wednesday, hitting $12.605. 64,038 shares of the company’s stock traded hands. Cempra Holdings LLC has a one year low of $5.26 and a one year high of $9.54. The stock’s 50-day moving average is $8.7 and its 200-day moving average is $7.50. The company’s market cap is $418.2 million.
Cempra Holdings LLC (NASDAQ:CEMP) last issued its quarterly earnings data on Tuesday, October 29th. The company reported ($0.41) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.29) by $0.12. The company had revenue of $1.20 million for the quarter, compared to the consensus estimate of $0.46 million. Analysts expect that Cempra Holdings LLC will post $-1.20 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Zacks downgraded shares of Cempra Holdings LLC from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, September 11th. They now have a $10.00 price target on the stock. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $12.30.
Cempra, Inc, formerly Cempra Holdings, LLC, is a development-stage and clinical-stage pharmaceutical company focused on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic and acute staphylococcal infections.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.